EP0979238A4 - Method of alleviating neuropathic pain - Google Patents

Method of alleviating neuropathic pain

Info

Publication number
EP0979238A4
EP0979238A4 EP97941027A EP97941027A EP0979238A4 EP 0979238 A4 EP0979238 A4 EP 0979238A4 EP 97941027 A EP97941027 A EP 97941027A EP 97941027 A EP97941027 A EP 97941027A EP 0979238 A4 EP0979238 A4 EP 0979238A4
Authority
EP
European Patent Office
Prior art keywords
neuropathic pain
alleviating neuropathic
alleviating
pain
neuropathic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP97941027A
Other languages
German (de)
French (fr)
Other versions
EP0979238A1 (en
Inventor
John S O'brien
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of California
Original Assignee
University of California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US1997/004143 external-priority patent/WO1997032895A1/en
Application filed by University of California filed Critical University of California
Publication of EP0979238A1 publication Critical patent/EP0979238A1/en
Publication of EP0979238A4 publication Critical patent/EP0979238A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EP97941027A 1997-03-05 1997-09-11 Method of alleviating neuropathic pain Withdrawn EP0979238A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
WOPCT/US97/04143 1997-03-05
PCT/US1997/004143 WO1997032895A1 (en) 1996-03-05 1997-03-05 Methods of alleviating neuropathic pain using prosaposin-derived peptides
PCT/US1997/016062 WO1998039357A1 (en) 1997-03-05 1997-09-11 Method of alleviating neuropathic pain

Publications (2)

Publication Number Publication Date
EP0979238A1 EP0979238A1 (en) 2000-02-16
EP0979238A4 true EP0979238A4 (en) 2000-08-23

Family

ID=85773700

Family Applications (1)

Application Number Title Priority Date Filing Date
EP97941027A Withdrawn EP0979238A4 (en) 1997-03-05 1997-09-11 Method of alleviating neuropathic pain

Country Status (3)

Country Link
EP (1) EP0979238A4 (en)
CA (1) CA2282827A1 (en)
WO (1) WO1998039357A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6271196B1 (en) * 1996-03-05 2001-08-07 Regents Of The University Of Ca Methods of alleviating neuropathic pain using prosaposin-derived peptides
AU745911B2 (en) * 1997-07-17 2002-04-11 Myelos Corporation Prosaposin receptor assay
US7109168B1 (en) * 2000-06-16 2006-09-19 Myelos Corporation Retro-inverso peptides derived from leukemia inhibitory factor
WO2000077029A1 (en) * 1999-06-16 2000-12-21 Myelos Corporation Retro-inverso peptides derived from leukemia inhibitory factor
IL147093A0 (en) * 1999-06-16 2002-08-14 Myelos Corp Retro-inverso peptides derived from interleukin-3
EP1183267A4 (en) * 1999-06-16 2002-09-18 Myelos Corp Retro-inverso peptides derived from interleukin-6
US7115571B1 (en) * 2000-06-16 2006-10-03 Myelos Corporation Retro-inverso peptides derived from interleukin-3
US7135461B1 (en) * 2000-06-16 2006-11-14 Myelos Corporation Retro-inverso peptides derived from interleukin-6
GB9914480D0 (en) 1999-06-21 1999-08-18 Univ Dundee Use of peptides
US8060209B2 (en) 2008-01-25 2011-11-15 Boston Scientific Neuromodulation Corporation Methods and systems of treating ischemia pain in visceral organs

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995003821A1 (en) * 1993-07-30 1995-02-09 The Regents Of The University Of California Prosaposin and cytokine-derived peptides as therapeutic agents
WO1997032895A1 (en) * 1996-03-05 1997-09-12 Regents Of The University Of California Methods of alleviating neuropathic pain using prosaposin-derived peptides
WO1998042746A2 (en) * 1997-03-24 1998-10-01 Myelos Corporation Synthetic saposin c-derived neurotrophic peptides

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3750197D1 (en) * 1986-04-22 1994-08-18 Salk Inst For Biological Studi Antagonists of fibroblast growth factor.
US5571787A (en) * 1993-07-30 1996-11-05 Myelos Corporation Prosaposin as a neurotrophic factor

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995003821A1 (en) * 1993-07-30 1995-02-09 The Regents Of The University Of California Prosaposin and cytokine-derived peptides as therapeutic agents
WO1997032895A1 (en) * 1996-03-05 1997-09-12 Regents Of The University Of California Methods of alleviating neuropathic pain using prosaposin-derived peptides
WO1998042746A2 (en) * 1997-03-24 1998-10-01 Myelos Corporation Synthetic saposin c-derived neurotrophic peptides

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
HIRAIWA, MASAO ET AL: "Cell death prevention, mitogen-activated protein kinase stimulation, and increased sulfatide concentrations in Schwann cells and oligodendrocytes by prosaposin and prosaptides", PROC. NATL. ACAD. SCI. U. S. A. (1997), 94(9), 4778-4781, 1997, XP002140103 *
See also references of WO9839357A1 *

Also Published As

Publication number Publication date
WO1998039357A1 (en) 1998-09-11
CA2282827A1 (en) 1998-09-11
EP0979238A1 (en) 2000-02-16

Similar Documents

Publication Publication Date Title
ZA977564B (en) Method of treatment
GB9715295D0 (en) Novel method of treatment
PL318452A1 (en) Method of obtaining peroxyperfluoropolyoxyalkylenes
GB9712866D0 (en) Novel method of treatment
EP0979238A4 (en) Method of alleviating neuropathic pain
PL330400A1 (en) Method of obtaining azacyclohexapeptides
GB9707693D0 (en) Novel method of treatment
PL335074A1 (en) Method of obtaining eprosartane
PL335075A1 (en) Method of obtaining eprosartane
GB9715298D0 (en) Novel method of treatment
HUP9901654A3 (en) Method of providing insulation
GB9715306D0 (en) Novel method of treatment
PL332077A1 (en) Method of obtaining omepraole
PL334901A1 (en) Method of obtaining benzothiazolones
PL313419A1 (en) Method of obtaining beta-naphtole
ZA971958B (en) Treatment of cocoa
PL339188A1 (en) Method of obtaining oxaphosphorin-2-amines
PL333977A1 (en) Method of obtaining benzisothiazolyn-3-ones
GB9618341D0 (en) Method of treatment
ZA973988B (en) Method of treatment
PL341358A1 (en) Method of obtaining paroxetin chlorhydride
PL340915A1 (en) Method of obtaining azacycloalkylalkanoyl pseudotetrapeptides
AU2002300005A1 (en) Method of alleviating neuropathic pain
PL336266A1 (en) Method of obtaining epsilon-caprolactams
PL341302A1 (en) Method of obtaining chlorobenzoxazoles

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19990930

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

RIC1 Information provided on ipc code assigned before grant

Free format text: 7C 07K 4/00 A, 7C 07K 7/00 B, 7C 07K 14/52 B, 7A 61K 38/10 B, 7A 61K 38/17 B, 7A 61K 38/19 B, 7C 07K 14/475 B

A4 Supplementary search report drawn up and despatched

Effective date: 20000706

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

17Q First examination report despatched

Effective date: 20040701

17Q First examination report despatched

Effective date: 20040701

RTI1 Title (correction)

Free format text: PROSAPTIDE 14-MER FOR USE IN THE TREATMENT OF MONONEUROPATY AND POLYNEUROPATY ASSOCIATED WITH DIABETES AND CHEMOTHERAPY

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20081212